Benznidazole treatment safety: the Médecins Sans Frontières experience in a large cohort of Bolivian patients with Chagas' disease-authors' response
J Antimicrob Chemother
.
2018 Apr 1;73(4):1115-1116.
doi: 10.1093/jac/dkx505.
Authors
Gilberto Marcelo Sperandio da Silva
1
,
Mauro Felippe Felix Mediano
1
,
Alejandro Marcel Hasslocher-Moreno
1
,
Marcelo Teixeira de Holanda
1
,
Andrea Silvestre de Sousa
1
,
Luiz Henrique Conde Sangenis
1
,
Juan-Carlos Cubides
2
,
Roberto Magalhães Saraiva
1
Affiliations
1
Evandro Chagas National Institute of Infectious Diseases (INI)-Oswaldo Cruz Foundation (Fiocruz), Manguinhos, Rio de Janeiro, Brazil.
2
Médecins Sans Frontières (MSF), Brazilian Medical Unit (BRAMU), Glória, Rio de Janeiro, Brazil.
PMID:
29309621
DOI:
10.1093/jac/dkx505
No abstract available
MeSH terms
Chagas Disease*
Cohort Studies
Humans
Nitroimidazoles*
Substances
Nitroimidazoles
benzonidazole